Table 5 Myocardial protection outcomes
From: Transitioning to Del Nido cardioplegia for all-comers: the next switching gear?
UNMATCHED | MATCHED | |||||
|---|---|---|---|---|---|---|
DN (n = 131) No.(%) or mean ± SD | CB (n = 251) No.(%) or mean ± SD | p value | DN (n = 130) % or mean ± SD | CB (n = 228) % or mean ± SD | p value | |
LVEF (%) | 52 ± 11 | 50 ± 12 | 0.22 | 52 ± 11 | 51 ± 10 | 0.37 |
Needing Inotropes for low cardiac outflow | 11(8.4) | 17(6.8) | 0.54 | 8.5 | 9.2 | 0.84 |
Postop Atrial Flutter | 34(26.0) | 42(16.7) | 0.04 | 25.4 | 19.0 | 0.43 |
Atrial Fibrillation de Novo | 35(26.7) | 74(29.5) | 0.63 | 26.9 | 26.5 | 0.93 |
Postop VT/VF | 8(6.1) | 7(2.8) | 0.16 | 5.4 | 4.1 | 0.63 |
Conduction Abnormalities | 6(4.6) | 13(5.2) | 1.0 | 4.6 | 4.6 | 1.0 |
Pacemaker | 5(3.8) | 9(3.6) | 1.0 | 3.9 | 4.5 | 0.80 |